Biotalys

IPO

Pioneering Precision Biocontrols

Public · Ghent, Belgium · Founded 2013 · $102.0M raised

Headquarters
Ghent
Employees
51–200
Founded
2013
Business Model
B2B
Total Funding
$102.0M
Last Round
$14.1M Private EquityMay 2026
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Biotalys is a Ghent, Belgium-based agricultural biotechnology company founded in 2013 as a spin-off from VIB (Flanders Institute for Biotechnology), listed on Euronext Brussels since July 2021. The company develops protein-based biocontrol solutions for sustainable crop protection in both pre- and post-harvest markets through its proprietary AGROBODY Foundry platform. Biotalys approach leverages the natural protein-binding properties of camelid antibody fragments (nanobodies) to create highly targeted, effective, and environmentally friendly alternatives to conventional chemical pesticides. The company solutions address fungal, insect, and other pest threats while meeting the growing demand from growers, food processors, and retailers for sustainable agricultural inputs. Biotalys has entered into strategic partnerships with major agri-businesses including Syngenta, and continues to advance its product pipeline through regulatory approval processes globally.

Summary

Biotalys is a Biotech company based in Ghent, Belgium, founded in 2013. It has raised $102.0M in total across 4 rounds, most recently a $14.1M Private Equity round in May 2026. Investors include Gimv, PMV and Ackermans & van Haaren.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Private EquityPrivate PlacementMay 2026
$14.1M

Sign up to see all 6 events

Funding: Series A through Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Biotalys on Indexed.vc
<a href="https://indexed.vc/companies/biotalys"><img src="https://indexed.vc/api/badge/company/biotalys" alt="Biotalys on Indexed.vc" width="260" height="76" /></a>